Anaphylactic Shock Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Bioavailability of Nasal Epinephrine
Condition:   Anaphylaxis Interventions:   Drug: Epinephrine Nasal Product, 1.6 mg;   Drug: Epinephrine nasal product, 1.6 mg + allergen;   Drug: Epinephrine Injection 0.3 mg;   Drug: Epinephrine Nasal Product, 3.2 mg;   Drug: Epinephrine Nasal Product, 3.2 mg + allergen Sponsor:   Nasus Pharma Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2021 Category: Research Source Type: clinical trials